Arrow, K (1963) Uncertainty and the welfare economics of medical care. American Economic Review
Ballard, C, Sorenson, S, Sharp, S (2007) Pharmacological therapy for people with Alzheimer's disease: the balance of clinical effectiveness, ethical issues and social and healthcare costs. Journal of Alzheimer's Disease
Berghmans, R, Berg, M, van den Burg, M et al (2004) Ethical issues of cost effectiveness analysis and guideline setting in mental health care. Journal of Medical Ethics
Braae, R, McNee, W, Moore, D (1999) Managing pharmaceutical expenditure while increasing access: the Pharmaceutical Management Agency (PHARMAC) experience. Pharmacoeconomics
Chisholm, D, Healey, A, Knapp, M (1997) QALYs and mental health. Social Psychiatry and Psychiatric Epidemiology
Drummond, M, Sculpher, M, Torrance, GW et al (2005) Methods for the Economic Evaluation of Health Care Programmes (3rd edn). Oxford University Press.
Duckett, SJ (2008) Drug policy down under: Australia's pharmaceutical benefits scheme. Health Care Financing Review
General Medical Council (2006) Good Medical Practice. GMC.
Gilbody, SM, House, AO, Sheldon, TA (2002) Outcomes research in mental health: systematic review. British Journal of Psychiatry
Graber, MA (2006) ‘Can I have that drug I saw on TV?’ Justice, cost-effectiveness, and the ethics of prescribing. Journal of the American Academy of Physician Assistants
Griffin, SC, Weatherly, HLA, Richardson, GA et al (2008) Methodological issues in undertaking independent cost-effectiveness analysis for NICE. The case of therapies for ADHD. European Journal of Health Economics
Hawkes, N, Elliot, F (2007) Pain relief drug ruled too costly for the NHS. The Times 2 August.
Higgins, JPT, Green, S (2008) Cochrane Handbook for Systematic Reviews of Interventions (version 5.0.0, updated February 2008). The Cochrane Collaboration (www.cochrane-handbook.org).
Johannesson, M (1995) A note on the depreciation of the societal perspective in economic evaluation of health care. Health Policy
Knapp, M (2003) Hidden costs of mental illness. British Journal of Psychiatry
Loewy, EL (1980) Cost should not be a factor in medical care. New England Journal of Medicine
McMahon, M, Morgan, S, Mitton, C (2006) The Common Drug Review: a NICE start for Canada?
National Institute for Clinical Excellence (2000) Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD). Technology Appraisal Guidance 13. NICE.
National Institute for Clinical Excellence (2002a) Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia (NICE Technology Appraisal Guidance 43). NICE.
National Institute for Clinical Excellence (2002b) Guidance on the Use of Computerised Cognitive Behavioural Therapy for Anxiety and Depression (NICE Technology Appraisal Guidance 51. NICE.
National Institute for Clinical Excellence (2003) A Guide to NICE. NICE.
National Institute for Clinical Excellence (2004) Guide to the Technology Appraisal Process. NICE.
National Institute for Health and Clinical Excellence (2006) Parent-training/education Programmes in the Management of Children with Conduct Disorders (NICE Technology Appraisal Guidance 102). NICE.
National Institute for Health and Clinical Excellence (2007) Donepezil, Galantamine, Rivastigmine (Review) and Memantine for the Treatment of Alzheimer's Disease (Amended). Technology Appraisal Guidance 111. NICE.
National Institute for Health and Clinical Excellence (2008b) Guide to the Methods of Technology Appraisal. NICE.
Raftery, J (2001) NICE: Faster access to modern treatments? Analysis of guidance on health technologies. BMJ
Raftery, J (2006) Review of NICE's recommendations, 1999–2005. BMJ
Rawlins, MD, Culyer, AJ (2004) National Institute for Clinical Excellence and its value judgements. BMJ
Rose, D (2010) NHS cuts ‘threaten talking therapies for psychiatric patients’. The Times, April 19.
Rutherford, D (1995) Routledge Dictionary of Economics. Routledge.
Sainsbury Centre for Mental Health (2006) Under Pressure: The Finances of Mental Health Trusts in 2006. SCMH.
Welsh, S, Deahl, MP (2002) Modern psychiatric ethics. Lancet
Williams, A (1991) The role of health economics in clinical decision-making: is it ethical?
Williams, A (1992) Cost-effectiveness analysis: is it ethical?
Journal of Medical Ethics